Cargando…

Correlation of Serum N-Acetylneuraminic Acid with the Risk of Moyamoya Disease

N-acetylneuraminic acid (Neu5Ac) is a functional metabolite and has been demonstrated to be a risk factor for cardiovascular diseases. It is not clear whether Neu5Ac is associated with a higher risk of cerebrovascular disorders, especially moyamoya disease (MMD). We sought to elucidate the associati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chenglong, Ge, Peicong, Zeng, Chaofan, Yu, Xiaofan, Zhai, Yuanren, Liu, Wei, He, Qiheng, Li, Junsheng, Liu, Xingju, Wang, Jia, Ye, Xun, Zhang, Qian, Wang, Rong, Zhang, Yan, Zhao, Jizong, Zhang, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296217/ https://www.ncbi.nlm.nih.gov/pubmed/37371391 http://dx.doi.org/10.3390/brainsci13060913

Ejemplares similares

Association of circulating branched-chain amino acids with risk of moyamoya disease
por: Zeng, Chaofan, et al.
Publicado: (2022)

Association between methionine sulfoxide and risk of moyamoya disease
por: Li, Junsheng, et al.
Publicado: (2023)

Integrated analysis of the association between methionine cycle and risk of moyamoya disease
por: Li, Junsheng, et al.
Publicado: (2023)

Serum Kynurenic Acid and Kynurenine Are Negatively Associated with the Risk of Adult Moyamoya Disease
por: Yu, Xiaofan, et al.
Publicado: (2022)

Association between systemic immune-inflammatory markers and the risk of moyamoya disease: a case-control study
por: Liu, Wei, et al.
Publicado: (2023)

Gut microbiota in adults with moyamoya disease: characteristics and biomarker identification
por: Yu, Xiaofan, et al.
Publicado: (2023)

Plasma urea cycle metabolite levels and the risk of moyamoya disease
por: Yu, Xiaofan, et al.
Publicado: (2023)

Hyperhomocysteinemia Is a Predictor for Poor Postoperative Angiogenesis in Adult Patients With Moyamoya Disease
por: He, Qiheng, et al.
Publicado: (2022)

Circulating choline pathway nutrients and risk of moyamoya disease
por: Ge, Peicong, et al.
Publicado: (2022)

Angiographic Outcomes of Direct and Combined Bypass Surgery in Moyamoya Disease
por: Ge, Peicong, et al.
Publicado: (2019)

Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease
por: Ge, Peicong, et al.
Publicado: (2020)

Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease
por: Ge, Peicong, et al.
Publicado: (2019)

Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease
por: Yu, Xiaofan, et al.
Publicado: (2022)

Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant
por: Ge, Peicong, et al.
Publicado: (2020)

Risk factors for postoperative ischemic complications in pediatric moyamoya disease
por: Deng, Xiaofeng, et al.
Publicado: (2021)

Digital subtraction angiographic characteristics of progression of moyamoya disease 6 months prior to surgical revascularisation
por: Ge, Peicong, et al.
Publicado: (2020)

FAM225B Is a Prognostic lncRNA for Patients with Recurrent Glioblastoma
por: Li, Junsheng, et al.
Publicado: (2020)

Cognitive Performance Profile in Pediatric Moyamoya Disease Patients and Its Relationship With Regional Cerebral Blood Perfusion
por: Li, Jiaxi, et al.
Publicado: (2019)

Homocysteine Level and Risk of Hemorrhage in Brain Arteriovenous Malformations
por: Zeng, Chaofan, et al.
Publicado: (2021)

Prognostic Significance of Homocysteine Level on Neurological Outcome in Brain Arteriovenous Malformations
por: Lin, Fa, et al.
Publicado: (2020)

High-Dimensional Immune Profiling by Mass Cytometry Revealed the Circulating Immune Cell Landscape in Patients With Intracranial Aneurysm
por: Ge, Peicong, et al.
Publicado: (2022)

Single-cell atlas reveals different immune environments between stable and vulnerable atherosclerotic plaques
por: Ge, Peicong, et al.
Publicado: (2023)

Development and validation of a model for predicting the risk of brain arteriovenous malformation rupture based on three-dimensional morphological features
por: Zhang, Shaosen, et al.
Publicado: (2022)

Corrigendum: Development and validation of a model for predicting the risk of brain arteriovenous malformation rupture based on three-dimensional morphological features
por: Zhang, Shaosen, et al.
Publicado: (2023)

Correlation of serum N-Acetylneuraminic acid with the risk and prognosis of acute coronary syndrome: a prospective cohort study
por: Li, Miao-Nan, et al.
Publicado: (2020)

Serum N-Acetylneuraminic Acid Is Associated with Atrial Fibrillation and Left Atrial Enlargement
por: Hu, Wei, et al.
Publicado: (2020)

Characterization of a novel N-acetylneuraminic acid lyase favoring N-acetylneuraminic acid synthesis
por: Ji, Wenyan, et al.
Publicado: (2015)

Circulating Inflammatory Cytokine Associated with Poor Prognosis in Moyamoya Disease: A Prospective Cohort Study
por: Liu, Wei, et al.
Publicado: (2023)

Reorganization of the Brain Structural Covariance Network in Ischemic Moyamoya Disease Revealed by Graph Theoretical Analysis
por: Wang, Peijing, et al.
Publicado: (2022)

A Treatment Option for Symptomatic Chronic Complete Internal Carotid Artery Occlusion: Hybrid Surgery
por: Yang, Yunna, et al.
Publicado: (2020)

Association Between Ultrasound Parameters and History of Ischemic or Hemorrhagic Stroke in Patients With Moyamoya Disease
por: Zheng, Shuai, et al.
Publicado: (2021)

Corrigendum: Characterization of a novel N-acetylneuraminic acid lyase favoring industrial N-acetylneuraminic acid synthesis process
por: Ji, Wenyan, et al.
Publicado: (2017)

Prognostic Value of Elevated Cardiac Troponin I After Aneurysmal Subarachnoid Hemorrhage
por: Lin, Fa, et al.
Publicado: (2021)

Neurodevelopmental defects in human cortical organoids with N-acetylneuraminic acid synthase mutation
por: Bu, Qian, et al.
Publicado: (2023)

Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease
por: HE, JIN, et al.
Publicado: (2014)

MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease
por: Lu, Junlin, et al.
Publicado: (2021)

Recent advances on N-acetylneuraminic acid: Physiological roles, applications, and biosynthesis
por: Zhao, Mingli, et al.
Publicado: (2023)

Multimodal treatments of brain arteriovenous malformations: a comparison of microsurgical timings after endovascular embolization
por: Zeng, Chaofan, et al.
Publicado: (2022)

Expression analysis of transfer RNA-derived fragments in the blood of patients with moyamoya disease: A preliminary study
por: Wang, Chengjun, et al.
Publicado: (2019)

Electroencephalographic features in pediatric patients with moyamoya disease in China
por: Lu, Jia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ahvq5e5illc071hanjq8lgapmd